Review



sybr green plus reagent kit  (TaKaRa)


Bioz Verified Symbol TaKaRa is a verified supplier
Bioz Manufacturer Symbol TaKaRa manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    TaKaRa sybr green plus reagent kit
    Sybr Green Plus Reagent Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 8957 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sybr green plus reagent kit/product/TaKaRa
    Average 99 stars, based on 8957 article reviews
    sybr green plus reagent kit - by Bioz Stars, 2026-02
    99/100 stars

    Images



    Similar Products

    99
    TaKaRa sybr green plus reagent kit
    Sybr Green Plus Reagent Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sybr green plus reagent kit/product/TaKaRa
    Average 99 stars, based on 1 article reviews
    sybr green plus reagent kit - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    TaKaRa sybr premix reagent kit
    Sybr Premix Reagent Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sybr premix reagent kit/product/TaKaRa
    Average 99 stars, based on 1 article reviews
    sybr premix reagent kit - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    TaKaRa rr037a sybr premix ex taq ii takara
    Rr037a Sybr Premix Ex Taq Ii Takara, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rr037a sybr premix ex taq ii takara/product/TaKaRa
    Average 99 stars, based on 1 article reviews
    rr037a sybr premix ex taq ii takara - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    TaKaRa synergetic binding reagent sybr green premix ex taq ii kit
    Synergetic Binding Reagent Sybr Green Premix Ex Taq Ii Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/synergetic binding reagent sybr green premix ex taq ii kit/product/TaKaRa
    Average 99 stars, based on 1 article reviews
    synergetic binding reagent sybr green premix ex taq ii kit - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    TaKaRa sybr qpcr premix
    The Role of VP22 phosphorylation in the in vitro viral life cycle. A. Generation of recombinant viruses carrying VP22 phosphorylation site mutations. Infectious clone plasmids containing VP22 phosphorylation site mutants (pDPV-VP22 QA ) or the corresponding revertant (pDPV-VP22 QA -Rev) were transfected into DEF cells. The recombinant viruses DPV-VP22 QA (phosphorylation-deficient virus) and DPV-VP22 QA -Rev (revertant virus) were obtained through plaque purification and lacked fluorescent markers. B. Multistep growth curve analysis of the recombinant viruses. DEF cells were infected with the virus at an MOI of 0.1, and samples were collected at 24, 48, 72, and 96 hpi for viral titer determination. The data represent the mean viral titers from three independent experiments, with standard deviations included. C-E. Quantitative PCR <t>(qPCR)</t> was performed to determine the impact of VP22 phosphorylation deficiency on viral adsorption (C), invasion efficiency (D), and viral DNA replication (E) by quantifying viral genome copy numbers. F. Viral assembly. Transmission electron microscopy (TEM) was used to visualize the secondary envelopment process of viral particles. G. Viral particle release capacity. Supernatants collected at different time points were analyzed using TCID₅₀ assays to assess the impact of VP22 phosphorylation deficiency on viral particle release efficiency (* P < 0.05, ** P < 0.01, *** P < 0.001).
    Sybr Qpcr Premix, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sybr qpcr premix/product/TaKaRa
    Average 99 stars, based on 1 article reviews
    sybr qpcr premix - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    TaKaRa sybr premix ex taqtm ii pcr master mix reagents kit
    The Role of VP22 phosphorylation in the in vitro viral life cycle. A. Generation of recombinant viruses carrying VP22 phosphorylation site mutations. Infectious clone plasmids containing VP22 phosphorylation site mutants (pDPV-VP22 QA ) or the corresponding revertant (pDPV-VP22 QA -Rev) were transfected into DEF cells. The recombinant viruses DPV-VP22 QA (phosphorylation-deficient virus) and DPV-VP22 QA -Rev (revertant virus) were obtained through plaque purification and lacked fluorescent markers. B. Multistep growth curve analysis of the recombinant viruses. DEF cells were infected with the virus at an MOI of 0.1, and samples were collected at 24, 48, 72, and 96 hpi for viral titer determination. The data represent the mean viral titers from three independent experiments, with standard deviations included. C-E. Quantitative PCR <t>(qPCR)</t> was performed to determine the impact of VP22 phosphorylation deficiency on viral adsorption (C), invasion efficiency (D), and viral DNA replication (E) by quantifying viral genome copy numbers. F. Viral assembly. Transmission electron microscopy (TEM) was used to visualize the secondary envelopment process of viral particles. G. Viral particle release capacity. Supernatants collected at different time points were analyzed using TCID₅₀ assays to assess the impact of VP22 phosphorylation deficiency on viral particle release efficiency (* P < 0.05, ** P < 0.01, *** P < 0.001).
    Sybr Premix Ex Taqtm Ii Pcr Master Mix Reagents Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sybr premix ex taqtm ii pcr master mix reagents kit/product/TaKaRa
    Average 99 stars, based on 1 article reviews
    sybr premix ex taqtm ii pcr master mix reagents kit - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    TaKaRa sybr premix ex taq reagent kit
    The Role of VP22 phosphorylation in the in vitro viral life cycle. A. Generation of recombinant viruses carrying VP22 phosphorylation site mutations. Infectious clone plasmids containing VP22 phosphorylation site mutants (pDPV-VP22 QA ) or the corresponding revertant (pDPV-VP22 QA -Rev) were transfected into DEF cells. The recombinant viruses DPV-VP22 QA (phosphorylation-deficient virus) and DPV-VP22 QA -Rev (revertant virus) were obtained through plaque purification and lacked fluorescent markers. B. Multistep growth curve analysis of the recombinant viruses. DEF cells were infected with the virus at an MOI of 0.1, and samples were collected at 24, 48, 72, and 96 hpi for viral titer determination. The data represent the mean viral titers from three independent experiments, with standard deviations included. C-E. Quantitative PCR <t>(qPCR)</t> was performed to determine the impact of VP22 phosphorylation deficiency on viral adsorption (C), invasion efficiency (D), and viral DNA replication (E) by quantifying viral genome copy numbers. F. Viral assembly. Transmission electron microscopy (TEM) was used to visualize the secondary envelopment process of viral particles. G. Viral particle release capacity. Supernatants collected at different time points were analyzed using TCID₅₀ assays to assess the impact of VP22 phosphorylation deficiency on viral particle release efficiency (* P < 0.05, ** P < 0.01, *** P < 0.001).
    Sybr Premix Ex Taq Reagent Kit, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sybr premix ex taq reagent kit/product/TaKaRa
    Average 99 stars, based on 1 article reviews
    sybr premix ex taq reagent kit - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    TaKaRa sybr premix ex taq
    The Role of VP22 phosphorylation in the in vitro viral life cycle. A. Generation of recombinant viruses carrying VP22 phosphorylation site mutations. Infectious clone plasmids containing VP22 phosphorylation site mutants (pDPV-VP22 QA ) or the corresponding revertant (pDPV-VP22 QA -Rev) were transfected into DEF cells. The recombinant viruses DPV-VP22 QA (phosphorylation-deficient virus) and DPV-VP22 QA -Rev (revertant virus) were obtained through plaque purification and lacked fluorescent markers. B. Multistep growth curve analysis of the recombinant viruses. DEF cells were infected with the virus at an MOI of 0.1, and samples were collected at 24, 48, 72, and 96 hpi for viral titer determination. The data represent the mean viral titers from three independent experiments, with standard deviations included. C-E. Quantitative PCR <t>(qPCR)</t> was performed to determine the impact of VP22 phosphorylation deficiency on viral adsorption (C), invasion efficiency (D), and viral DNA replication (E) by quantifying viral genome copy numbers. F. Viral assembly. Transmission electron microscopy (TEM) was used to visualize the secondary envelopment process of viral particles. G. Viral particle release capacity. Supernatants collected at different time points were analyzed using TCID₅₀ assays to assess the impact of VP22 phosphorylation deficiency on viral particle release efficiency (* P < 0.05, ** P < 0.01, *** P < 0.001).
    Sybr Premix Ex Taq, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sybr premix ex taq/product/TaKaRa
    Average 99 stars, based on 1 article reviews
    sybr premix ex taq - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    Image Search Results


    The Role of VP22 phosphorylation in the in vitro viral life cycle. A. Generation of recombinant viruses carrying VP22 phosphorylation site mutations. Infectious clone plasmids containing VP22 phosphorylation site mutants (pDPV-VP22 QA ) or the corresponding revertant (pDPV-VP22 QA -Rev) were transfected into DEF cells. The recombinant viruses DPV-VP22 QA (phosphorylation-deficient virus) and DPV-VP22 QA -Rev (revertant virus) were obtained through plaque purification and lacked fluorescent markers. B. Multistep growth curve analysis of the recombinant viruses. DEF cells were infected with the virus at an MOI of 0.1, and samples were collected at 24, 48, 72, and 96 hpi for viral titer determination. The data represent the mean viral titers from three independent experiments, with standard deviations included. C-E. Quantitative PCR (qPCR) was performed to determine the impact of VP22 phosphorylation deficiency on viral adsorption (C), invasion efficiency (D), and viral DNA replication (E) by quantifying viral genome copy numbers. F. Viral assembly. Transmission electron microscopy (TEM) was used to visualize the secondary envelopment process of viral particles. G. Viral particle release capacity. Supernatants collected at different time points were analyzed using TCID₅₀ assays to assess the impact of VP22 phosphorylation deficiency on viral particle release efficiency (* P < 0.05, ** P < 0.01, *** P < 0.001).

    Journal: Poultry Science

    Article Title: Pioneering discovery: US3-phosphorylated sites on VP22 orchestrate duck plague virus release and pathogenicity

    doi: 10.1016/j.psj.2025.105908

    Figure Lengend Snippet: The Role of VP22 phosphorylation in the in vitro viral life cycle. A. Generation of recombinant viruses carrying VP22 phosphorylation site mutations. Infectious clone plasmids containing VP22 phosphorylation site mutants (pDPV-VP22 QA ) or the corresponding revertant (pDPV-VP22 QA -Rev) were transfected into DEF cells. The recombinant viruses DPV-VP22 QA (phosphorylation-deficient virus) and DPV-VP22 QA -Rev (revertant virus) were obtained through plaque purification and lacked fluorescent markers. B. Multistep growth curve analysis of the recombinant viruses. DEF cells were infected with the virus at an MOI of 0.1, and samples were collected at 24, 48, 72, and 96 hpi for viral titer determination. The data represent the mean viral titers from three independent experiments, with standard deviations included. C-E. Quantitative PCR (qPCR) was performed to determine the impact of VP22 phosphorylation deficiency on viral adsorption (C), invasion efficiency (D), and viral DNA replication (E) by quantifying viral genome copy numbers. F. Viral assembly. Transmission electron microscopy (TEM) was used to visualize the secondary envelopment process of viral particles. G. Viral particle release capacity. Supernatants collected at different time points were analyzed using TCID₅₀ assays to assess the impact of VP22 phosphorylation deficiency on viral particle release efficiency (* P < 0.05, ** P < 0.01, *** P < 0.001).

    Article Snippet: Quantitative real-time PCR (qRT-PCR) was performed using SYBR qPCR Premix (Cat No: RR047A; Takara, Japan).

    Techniques: Phospho-proteomics, In Vitro, Recombinant, Transfection, Virus, Purification, Infection, Real-time Polymerase Chain Reaction, Adsorption, Transmission Assay, Electron Microscopy

    Accumulation of most viral gene mRNAs requires VP22 phosphorylation. A. Quantification of viral gene expression following infection. DEF cells were infected with 1 MOI of the virus, and total RNA was extracted at 24 hpi. RT-qPCR was performed to assess the expression levels of target genes, with the data normalized using GraphPad Prism 9. The relative gene expression levels were calculated using the 2 -ΔΔCt method. B. Dynamic expression analysis of viral genes. RT-qPCR was used to analyze the expression patterns of viral genes at different transcriptional stages: immediate-early (UL54, ICP4, US1), early (US3, UL23, UL29), and late (UL41, UL47, UL48). 18S rRNA served as an internal reference for normalization. Relative expression levels in the DPV CHv50-infected group were calculated using the 2 -ΔΔCt method, and the data were presented as the fold change relative to the DPV CHv50 group. C. Protein-level analysis of viral gene expression. DEF cells were infected with virus at an MOI of 1, and protein samples were collected at 24 hpi for detection by Western blotting.

    Journal: Poultry Science

    Article Title: Pioneering discovery: US3-phosphorylated sites on VP22 orchestrate duck plague virus release and pathogenicity

    doi: 10.1016/j.psj.2025.105908

    Figure Lengend Snippet: Accumulation of most viral gene mRNAs requires VP22 phosphorylation. A. Quantification of viral gene expression following infection. DEF cells were infected with 1 MOI of the virus, and total RNA was extracted at 24 hpi. RT-qPCR was performed to assess the expression levels of target genes, with the data normalized using GraphPad Prism 9. The relative gene expression levels were calculated using the 2 -ΔΔCt method. B. Dynamic expression analysis of viral genes. RT-qPCR was used to analyze the expression patterns of viral genes at different transcriptional stages: immediate-early (UL54, ICP4, US1), early (US3, UL23, UL29), and late (UL41, UL47, UL48). 18S rRNA served as an internal reference for normalization. Relative expression levels in the DPV CHv50-infected group were calculated using the 2 -ΔΔCt method, and the data were presented as the fold change relative to the DPV CHv50 group. C. Protein-level analysis of viral gene expression. DEF cells were infected with virus at an MOI of 1, and protein samples were collected at 24 hpi for detection by Western blotting.

    Article Snippet: Quantitative real-time PCR (qRT-PCR) was performed using SYBR qPCR Premix (Cat No: RR047A; Takara, Japan).

    Techniques: Phospho-proteomics, Gene Expression, Infection, Virus, Quantitative RT-PCR, Expressing, Western Blot